ACERS, Homerton University Hospital NHS Foundation Trust, London, UK
Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Thorax. 2019 Jun;74(6):600-603. doi: 10.1136/thoraxjnl-2018-211732. Epub 2019 Apr 26.
We developed a chronic obstructive pulmonary disease (COPD) patient-reported experience measure (PREM-C9). 174 patients with COPD (86 [49%] with a confirmed diagnosis and 88 [51%] with a self-reported diagnosis of COPD) completed a 38-item list, COPD Assessment Test (CAT) and Hospital Anxiety and Depression Scale (HADS). Hierarchical and Rasch analysis produced a 9-item list (PREM-C9). It demonstrated fit to the Rasch model (χ² p=0.33) and correlated moderately with CAT (r=0.42), HAD-anxiety (r=0.30) and HAD-depression (r=0.41) (p<0.05). A substudy confirmed its ability to detect change prepulmonary and postpulmonary rehabilitation. The PREM-C9 is a simple, valid measure of experience of patients living with COPD, validated in this study population with mild to very severe disease; it may be a useful measure in research and clinical audits.
我们开发了一种慢性阻塞性肺疾病（COPD）患者报告体验量表（PREM-C9）。174 名 COPD 患者（86 名[49%]有确诊诊断，88 名[51%]有自我报告的 COPD 诊断）完成了 38 项的清单、COPD 评估测试（CAT）和医院焦虑和抑郁量表（HADS）。层次和 Rasch 分析产生了 9 项清单（PREM-C9）。它符合 Rasch 模型（χ² p=0.33），与 CAT（r=0.42）、HAD-焦虑（r=0.30）和 HAD-抑郁（r=0.41）中度相关（p<0.05）。一项子研究证实了它在肺前和肺后康复后检测变化的能力。PREM-C9 是一种简单、有效的 COPD 患者体验测量方法，在本研究人群中具有轻度至非常严重的疾病得到验证；它可能是研究和临床审计中的有用测量方法。
